176 related articles for article (PubMed ID: 20576438)
1. Spectroscopic characterization of the inclusion complexes of luteolin with native and derivatized beta-cyclodextrin.
Jullian C; Cifuentes C; Alfaro M; Miranda S; Barriga G; Olea-Azar C
Bioorg Med Chem; 2010 Jul; 18(14):5025-31. PubMed ID: 20576438
[TBL] [Abstract][Full Text] [Related]
2. Complexation of morin with three kinds of cyclodextrin. A thermodynamic and reactivity study.
Jullian C; Orosteguis T; Pérez-Cruz F; Sánchez P; Mendizabal F; Olea-Azar C
Spectrochim Acta A Mol Biomol Spectrosc; 2008 Nov; 71(1):269-75. PubMed ID: 18262835
[TBL] [Abstract][Full Text] [Related]
3. Effect of beta-cyclodextrin and hydroxypropyl beta-cyclodextrin complexation on physicochemical properties and antimicrobial activity of cefdinir.
Aleem O; Kuchekar B; Pore Y; Late S
J Pharm Biomed Anal; 2008 Jul; 47(3):535-40. PubMed ID: 18367363
[TBL] [Abstract][Full Text] [Related]
4. Studies of inclusion complexes of natural and modified cyclodextrin with (+)catechin by NMR and molecular modeling.
Jullian C; Miranda S; Zapata-Torres G; Mendizábal F; Olea-Azar C
Bioorg Med Chem; 2007 May; 15(9):3217-24. PubMed ID: 17350847
[TBL] [Abstract][Full Text] [Related]
5. Preparation and characterization of inclusion complexes of prazosin hydrochloride with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
Liu L; Zhu S
J Pharm Biomed Anal; 2006 Jan; 40(1):122-7. PubMed ID: 16095859
[TBL] [Abstract][Full Text] [Related]
6. Study on the complexation of isoquercitrin with beta-cyclodextrin and its derivatives by spectroscopy.
Wang Y; Qiao X; Li W; Zhou Y; Jiao Y; Yang C; Dong C; Inoue Y; Shuang S
Anal Chim Acta; 2009 Sep; 650(1):124-30. PubMed ID: 19720183
[TBL] [Abstract][Full Text] [Related]
7. Preparation and characterization of inclusion complexes of pefloxacin mesylate with three kinds of cyclodextrins.
Chao JB; Tong HB; Liu DS; Huang SP
Spectrochim Acta A Mol Biomol Spectrosc; 2006 May; 64(1):166-70. PubMed ID: 16098803
[TBL] [Abstract][Full Text] [Related]
8. Molecular encapsulation of 5-nitroindazole derivatives in 2,6-dimethyl-beta-cyclodextrin: electrochemical and spectroscopic studies.
Pérez-Cruz F; Jullian C; Rodriguez J; Arán VJ; Olea-Azar C
Bioorg Med Chem; 2009 Jul; 17(13):4604-11. PubMed ID: 19464903
[TBL] [Abstract][Full Text] [Related]
9. Characterization, phase-solubility, and molecular modeling of inclusion complex of 5-nitroindazole derivative with cyclodextrins.
Jullian C; Morales-Montecinos J; Zapata-Torres G; Aguilera B; Rodriguez J; Arán V; Olea-Azar C
Bioorg Med Chem; 2008 May; 16(9):5078-84. PubMed ID: 18375132
[TBL] [Abstract][Full Text] [Related]
10. Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified beta-cyclodextrin.
Figueiras A; Carvalho RA; Ribeiro L; Torres-Labandeira JJ; Veiga FJ
Eur J Pharm Biopharm; 2007 Sep; 67(2):531-9. PubMed ID: 17451924
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of the inclusion complex of the antibacterial agent triclosan with cyclomaltoheptaose and NMR study of its molecular encapsulation in positively and negatively charged cyclomaltoheptaose derivatives.
Paulidou A; Maffeo D; Yannakopoulou K; Mavridis IM
Carbohydr Res; 2008 Oct; 343(15):2634-40. PubMed ID: 18684438
[TBL] [Abstract][Full Text] [Related]
12. Physicochemical characteristics and bioavailability of a novel intestinal metabolite of ginseng saponin (IH901) complexed with beta-cyclodextrin.
Lee PS; Han JY; Song TW; Sung JH; Kwon OS; Song S; Chung YB
Int J Pharm; 2006 Jun; 316(1-2):29-36. PubMed ID: 16574357
[TBL] [Abstract][Full Text] [Related]
13. Spectroscopic studies of the interaction of 3-(2-thienyl)-[1,2,3]triazolo[1,5-a]pyridine with 2,6-dimethyl-β-cyclodextrin and ctDNA.
Cifuentes T; Cayupi J; Celis-Barros C; Zapata-Torres G; Ballesteros R; Ballesteros-Garrido R; Abarca B; Jullian C
Org Biomol Chem; 2016 Oct; 14(41):9760-9767. PubMed ID: 27714322
[TBL] [Abstract][Full Text] [Related]
14. Molecular dynamics simulations of UC781-cyclodextrins inclusion complexes in aqueous solution.
Boonyarattanakalin K; Wolschann P; Toochinda P; Lawtrakul L
Eur J Pharm Sci; 2012 Nov; 47(4):752-8. PubMed ID: 22922099
[TBL] [Abstract][Full Text] [Related]
15. NMR studies of the inclusion complex between beta-cyclodextrin and paroxetine.
Bernini A; Spiga O; Ciutti A; Scarselli M; Bottoni G; Mascagni P; Niccolai N
Eur J Pharm Sci; 2004 Aug; 22(5):445-50. PubMed ID: 15265514
[TBL] [Abstract][Full Text] [Related]
16. Inclusion complexes of azadirachtin with native and methylated cyclodextrins: solubilization and binding ability.
Liu Y; Chen GS; Chen Y; Lin J
Bioorg Med Chem; 2005 Jun; 13(12):4037-42. PubMed ID: 15911316
[TBL] [Abstract][Full Text] [Related]
17. Melarsoprol-cyclodextrins inclusion complexes.
Gibaud S; Zirar SB; Mutzenhardt P; Fries I; Astier A
Int J Pharm; 2005 Dec; 306(1-2):107-21. PubMed ID: 16253447
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the separation mechanism of electrokinetic chromatography with a microemulsion and cyclodextrins using NMR and molecular modeling.
Melani F; Giannini I; Pasquini B; Orlandini S; Pinzauti S; Furlanetto S
Electrophoresis; 2011 Nov; 32(21):3062-9. PubMed ID: 22002863
[TBL] [Abstract][Full Text] [Related]
19. Inclusion complexes of quercetin with three β-cyclodextrins derivatives at physiological pH: spectroscopic study and antioxidant activity.
Liu M; Dong L; Chen A; Zheng Y; Sun D; Wang X; Wang B
Spectrochim Acta A Mol Biomol Spectrosc; 2013 Nov; 115():854-60. PubMed ID: 23892509
[TBL] [Abstract][Full Text] [Related]
20. Cyclodextrin solubilization of the antibacterial agents triclosan and triclocarban: formation of aggregates and higher-order complexes.
Duan MS; Zhao N; Ossurardóttir IB; Thorsteinsson T; Loftsson T
Int J Pharm; 2005 Jun; 297(1-2):213-22. PubMed ID: 15885935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
